Literature DB >> 30915547

Response to "Predictors of rituximab-related neutropenia in Japanese children with steroid-dependent nephrotic syndrome".

Tim Ulinski1,2, Jean Daniel Delbet3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30915547     DOI： 10.1007/s00467-019-04239-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  3 in total

1.  Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery.

Authors:  Anne-Laure Sellier-Leclerc; Véronique Baudouin; Thérésa Kwon; Marie-Alice Macher; Valérie Guérin; Hélène Lapillonne; Georges Deschênes; Tim Ulinski
Journal:  Nephrol Dial Transplant       Date:  2011-08-01       Impact factor: 5.992

2.  Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximab.

Authors:  Koichi Kamei; Kenji Ishikura; Mayumi Sako; Kunihiko Aya; Ryojiro Tanaka; Kandai Nozu; Hiroshi Kaito; Koichi Nakanishi; Yoshiyuki Ohtomo; Kenichiro Miura; Shori Takahashi; Tetsuji Morimoto; Wataru Kubota; Shuichi Ito; Hidefumi Nakamura; Kazumoto Iijima
Journal:  Pediatr Nephrol       Date:  2017-06-29       Impact factor: 3.714

3.  Idiopathic nephrotic syndrome and rituximab: may we predict circulating B lymphocytes recovery?

Authors:  Jean Daniel Delbet; Gael Leclerc; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2018-12-12       Impact factor: 3.714
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.